Recent advances in host-directed therapies for tuberculosis and malaria
KC Matteucci, AAS Correa, DL Costa - Frontiers in Cellular and …, 2022 - frontiersin.org
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, and malaria,
caused by parasites from the Plasmodium genus, are two of the major causes of death due …
caused by parasites from the Plasmodium genus, are two of the major causes of death due …
Host-directed therapies for malaria and tuberculosis: Common infection strategies and repurposed drugs
P Baindara, S Agrawal, OL Franco - Expert Review of Anti-infective …, 2022 - Taylor & Francis
Introduction Malaria and tuberculosis are highly infectious diseases declared a global health
emergency by the World Health Organization, and together they account for more than 1.5 …
emergency by the World Health Organization, and together they account for more than 1.5 …
Host directed therapies for tuberculosis: futures strategies for an ancient disease
I Palucci, G Delogu - Chemotherapy, 2018 - karger.com
The emergence and spread of drug-resistant strains of Mycobacterium tuberculosis is
worsening the global threat of tuberculosis (TB). There is a need and urgency for the …
worsening the global threat of tuberculosis (TB). There is a need and urgency for the …
Host-directed therapeutic strategies for tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of
morbidity and mortality in humans worldwide. Currently, the standard treatment for TB …
morbidity and mortality in humans worldwide. Currently, the standard treatment for TB …
Host-directed therapeutics as a novel approach for tuberculosis treatment
YR Kim, CS Yang - Journal of microbiology and …, 2017 - repository.hanyang.ac.kr
Despite significant efforts to improve the treatment of tuberculosis (TB), it remains a
prevalent infectious disease worldwide owing to the limitations of current TB therapeutic …
prevalent infectious disease worldwide owing to the limitations of current TB therapeutic …
[HTML][HTML] Advancing host-directed therapy for tuberculosis: new therapeutic insights from the Toxoplasma gondii
CS Yang - Microbial Cell, 2017 - ncbi.nlm.nih.gov
Tuberculosis (TB) drug-development strategies, a wide range of candidate host-directed
therapies (HDT) s-including new and repurposed drugs, biologics, and cellular therapies …
therapies (HDT) s-including new and repurposed drugs, biologics, and cellular therapies …
Host-directed therapies to combat tuberculosis and associated non-communicable diseases
P Baindara - Microbial pathogenesis, 2019 - Elsevier
Mycobacterium tuberculosis (Mtb) has coevolved with a human host to evade and exploit the
immune system in multiple ways. Mtb is an enormously successful human pathogen that can …
immune system in multiple ways. Mtb is an enormously successful human pathogen that can …
Host-directed therapies offer novel opportunities for the fight against tuberculosis
A Machelart, OR Song, E Hoffmann, P Brodin - Drug discovery today, 2017 - Elsevier
Highlights•HDT offers novel opportunities as treatment for TB.•HDT may prove useful to
combat MDR and XDR-TB.•Intracellular high-throughput phenotypic assays accelerates …
combat MDR and XDR-TB.•Intracellular high-throughput phenotypic assays accelerates …
[HTML][HTML] Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis
Tuberculosis (TB) maintains its infamous status regarding its detrimental effect on global
health, causing the highest mortality by a single infectious agent. The presence of resistance …
health, causing the highest mortality by a single infectious agent. The presence of resistance …
Host-directed therapy against tuberculosis: Concept and recent developments
S Udinia, M Suar, D Kumar - Journal of Biosciences, 2023 - Springer
Tuberculosis (TB) continues to remain at the forefront of the infectious disease burden
globally, albeit with some aberrations during the COVID-19 pandemic. Among many factors …
globally, albeit with some aberrations during the COVID-19 pandemic. Among many factors …